UV or not UV: Metals are the answer

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 2, 2008, Pages 268-270

  Meyskens Jr , Frank L ^a   Berwick, Marianne ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN; METAL; METALLOTHIONEIN;

CANCER EPIDEMIOLOGY; CANCER RISK; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MELANOCYTE; MELANOMA; MELANOSOME; NOTE; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SUN EXPOSURE; TOTAL HIP PROSTHESIS; ULTRAVIOLET RADIATION;

COCARCINOGENESIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MELANOMA; METALS; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 39449119998     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0653     Document Type: Note

References (34)

1. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005;353:2135-47.
2. Yang S, Irani K, Heffron SE, Jurnak F, Meyskens FL, Jr. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther 2005;4:1923-35.
3. Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol 2007;25:1606-20. Review.
4. Benjamin CL, Ananthaswamy HN. P53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 2006. Epub ahead of print.
5. Kricker A, Armstrong BK, Goumas C, et al. Ambient UV personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007;18:295-304.
6. Gandidi S, Sera F, Cattaruzza MS, et al. Meta-analalysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005;41:45-60. Review.
7. Healy E. Melanocortin-1 receptor variants, pigmentation and skin cancer susceptibility. Photodermatol Photoimmunol Photomed 2004;20:283-8.
8. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997;277:1439-44.
9. Reelfs O, Tyrrell RM, Pourzand C. Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-κB in human skin fibroblasts. J Invest Dermatol 2004;122:1440-7.
10. Mitani H, Koshiishi I, Sumita T, Imanari T. Prevention of the photodamage in the hairless mouse dorsal skin by kojic acid as an iron chelator. Eur J Pharmacol 2001;411:169-74.
11. Wondrak GT. Let the sun shine in: mechanisms and potential for therapeutics in skin photodamage. Curr Opin Investig Drugs 2007;8:390-400. Review.
12. Hauser JE, Kadekaro AL, Kavanagh RJ, et al. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human malanocytes. Pigment Cell Res 2006;19:303-14.
13. Scott MC, Wakamatsu K, Ito S, et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J Cell Sci 2002;115:2349-55.
14. Landi MT, Bauer J, Pfeiffer RM, et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 2006;313:521-2.
15. Weinlich G, Eisendle K, Hassler E, Baltaci M, Fritsch PO, Zelger B. Metallothionein - overexpression as highly significant prognostic factor in melanoma: a prospective study on 1270 patients. Br J Cancer 2006;94:835-41.
16. Rhodes AR, Seki Y, Fitzpatrick TB, Stern RS. Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation. Cancer 1988;61:358-69.
17. Sarna T, Froncisz W, Hyde JS. Cu2+ probe of metal-ion binding sites in melanin using electron paramagnetic resonance spectroscopy. II. Natural melanin. Arch Biochem Biophys 1980;202:304-13.
18. Fukumoto M, Yoshimura N, Kurohara A, Yoshida S. Ga-67 visualizing metastases of malignant melanoma to gastric cancer. Clin Nucl Med 1997;22:415-6.
19. Austin DF, Reynolds P. Occupation and malignant melanoma of the skin. Recent Results Cancer Res 1986;102:98-107.
20. Dubrow R. Malignant melanoma in the printing industry. Am J Ind Med 1986;10:119-26.
21. Nielsen H, Henriksen L, Olsen JH. Malignant melanoma among lithographers. Scand J Work Environ Health 1996;22:108-11.
22. Bouchardy C, Schuler G, Minder C, et al. Cancer risk by occupation and socioeconomic group among men - a study by the Association of Swiss Cancer Registries. Scand J Work Environ Health 2002;28:1-88.
23. Perez-Gomez B, Pollan M, Gustavsson P, Plato N, Aragones N, Lopez-Abente G. Cutaneous melanoma: hints from occupational risks by anatomic site in Swedish men. Occup Environ Med 2004;61:117-26.
24. Nelemans PJ, Scholte R, Groendal H, et al. Melanoma and occupation: results of a case-control study in the Netherlands. Br J Ind Med 1993;30:642-6.
25. Nichols L, Sorahan T. Cancer incidence and cancer mortality in a cohort of UK semiconductor workers, 1970-2002. Occup Med (Lond) 2005;55:625-30.
26. Clapp RW. Mortality among US employees of a large computer manufacturing company: 1969-2001. Environ Health 2006;5:30-44.
27. Sinks T, Steele G, Smith AB, Watkins K, Shults RA. Mortality among workers exposed to polychlorinated biphenyls. Am J Epidemiol 1992;136:389-98.
28. Loomis D, Browing SR, Schenck AP, Gregory E, Savitz DA. Cancer Mortality among electric utility worker exposed to polychlorinated biphenyls. Occup Environ Med 1197;54:720-8.
29. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL. Toenail arsenic content and cutaneous melanoma in Iowa. Am J Epidemiol 2004;160:679-87.
30. Nyren O, McLaughlin JK, Gridley G, et al. Cancer risk after hip replacement with metal implants: a population based cohort study in Sweden. J Natl Cancer Inst 1995;87:28-33.
31. Onega T, Baven J, Mackenzie T. Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1532-7.
32. Visuri TI, Pukkala F, Pulkkinen P, Paavolainen P. Cancer incidence and causes of death among total hip replacement patients: a review based on Nordic cohorts with a special emphasis on metal-on-metal bearings. Proc Inst Mech Eng (H) 2006;220:399-407.
33. Silva M, Heisel C, Schmalzried TP. Metal-on-metal total hip replacement. Clin Orthop 2005;430:53-61.
34. Yiakouvaki A, Savoviæ J, Al-Qenaei A, Dowden J, Pourzand C. Caged-iron chelators a novel approach towards protecting skin cells against UVA-induced necrotic cell death. J Invest Dermatol 2006;126:2287-95.